Authors


Eric Levine, M.P.H.

Latest:

CMS’ RADV Strategy Will Reverberate Throughout Health Plan Operations

To prepare for CMS’ new risk adjustment data validation (RADV) strategy, Medicare Advantage plans must take a coordinated, organization-wide approach.


Sudhakar Velamoor

Latest:

Drug Discount Programs Poised to Change with New Tech, Pharma Execs Survey Finds

It is somewhat mind-boggling in 2024 that more than one-third of pharma organizations still rely on manual entry of data into Excel spreadsheets to track duplicate discounts that can cost millions of dollars a year in lost revenue


Margaret Murray, M.P.A.

Latest:

Common Challenges in Health Systems of Great Britain and the United States Offer Valuable Learning Opportunities

The National Health Service provides some lessons — both good and bad — around models of coverage expansion.


Minal Patel, M.D., M.P.H.

Latest:

Could the Pandemic Put an End to Medical Overtreatment?

COVID-19 pandemic may present an opportunity to hit a reset button on American healthcare that could winnow out unnecessary, wasteful services and prescriptions.


Dave Palmer

Latest:

Streamlining Medicare Advantage Enrollment is Key for Health Plans to Thrive During Surge

As soon as next year, enrollment in Medicare Advantage plans are expected to exceed 50% of the entire Medicare eligible population. For the first time ever, the majority of Medicare beneficiaries will receive health benefits delivered by a private health plan, rather than through traditional, fee-for-service Medicare.


David Lareau

Latest:

Adapting EHRs for the 21st Century

There is a great deal of speculation, and apprehension, in the healthcare industry about the 21st Century Cures Act and what it will mean for EHRs and the clinicians who use them.


Mark D. Tyson II, M.D., MPH

Latest:

How Community-Based Gene Therapy Is Changing Treatment and Improving Quality of Life for Patients With BCG-Unresponsive NMIBC

An expert discusses how community-based gene therapy administration has broadened treatment options for patients with BCG-unresponsive NMIBC by providing easier logistics compared with complex chemotherapy regimens, ultimately expanding bladder-sparing approaches and avoiding radical cystectomy in younger, sexually active patients.


Roshni Patel

Latest:

Headaches Behind the Eyes – Triggers, Treatments and How to Prevent Them

Across the world, almost everyone has experienced a bad headache and knows the unpleasant symptoms that can come with it. Many have also faced migraines, which can cause dizziness, nausea and stomach pain - as well as impacting your vision.


Laura Kohlhagen, M.D., MBA

Latest:

Advancing Care Coordination, Equity and AI Integration | Predictions for 2025

A prediction for 2025 from Laura Kohlhagen, M.D., MBA, chief medical officer, of Altera Digital Health.


Jack Kain, PharmD

Latest:

CDC’s Proposed Opioid Prescribing Guideline: Does it Fall Short on Drug Testing?

Last month, the Centers for Disease Control and Prevention shared a draft update to its Clinical Practice Guideline for Prescribing Opioids. The proposed revision comes as the nation’s overdose death rate reaches an all-time high, fueled largely by the economic and psychological strains and lack of healthcare access caused by COVID-19.


Claire Anderson

Latest:

Healthcare Needs Tech Workers — But Tech Workers Also Need the Healthcare Industry

Pandemic-triggered changes in the healthcare industry have required hospitals, clinics, and other healthcare facilities to scale up their technology operations, resulting in high demand for tech experts.


Diana Brixner, Ph.D., B.Pharm., FAMCP

Latest:

Advancing Diagnostic Precision in Type 1 Diabetes

Panelists discuss how autoantibody testing has high diagnostic accuracy with nearly 100% conversion to hyperglycemia when two or more antibodies are present, though timing of testing is crucial and retesting may be necessary since antibody levels can fluctuate over time.


Ian Tong,M.D.

Latest:

Tackling LGBTQ+ Bias in Healthcare

The chief medical officer for Grand Rounds Health and Doctor on Demand says the healthcare industry needs to be committed to creating equitable and inclusive environments.


James J. Oh

Latest:

Don’t Panic. Or Don’t Get Your Hopes Up. The FTC’s Proposed Rule Banning Non-competes May or May Not Go Into Effect

Even if the Federal Trade Commission were to ban noncompetes, legal challenges to block the ban are nearly certain.


Ken Tarkoff

Latest:

Bringing Real World Evidence into the Care Setting

Real-world evidence (RWE) has the potential to be a transformative tool for healthcare providers to enhance the care they deliver to patients.
















© 2025 MJH Life Sciences

All rights reserved.